34045369|t|Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson's Disease.
34045369|a|Parkinson's disease (PD) is the most prevalent neurodegenerative motor disorder. While PD has been attributed to dopaminergic neuronal death in substantia nigra pars compacta (SNpc), accumulating lines of evidence have suggested that reactive astrogliosis is critically involved in PD pathology. These pathological changes are associated with alpha-synuclein aggregation, which is more prone to be induced by an A53T mutation. Therefore, the overexpression of A53T-mutated alpha-synuclein (A53T-alpha-syn) has been utilized as a popular animal model of PD. However, this animal model only shows marginal-to-moderate extents of reactive astrogliosis and astrocytic alpha-synuclein accumulation, while these phenomena are prominent in human PD brains. Here we show that Adeno-GFAP-GFP virus injection into SNpc causes severe reactive astrogliosis and exacerbates the A53T-alpha-syn-mediated PD pathology. In particular, we demonstrate that AAV-CMV-A53T-alpha-syn injection, when combined with Adeno-GFAP-GFP, causes more significant loss of dopaminergic neuronal tyrosine hydroxylase level and gain of astrocytic GFAP and GABA levels. Moreover, the combination of AAV-CMV-A53T-alpha-syn and Adeno-GFAP-GFP causes an extensive astrocytic alpha-syn expression, just as in human PD brains. These results are in marked contrast to previous reports that AAV-CMV-A53T-alpha-syn alone causes alpha-syn expression mostly in neurons but rarely in astrocytes. Furthermore, the combination causes a severe PD-like motor dysfunction as assessed by rotarod and cylinder tests within three weeks from the virus injection, whereas Adeno-GFAP-GFP alone or AAV-CMV-A53T-alpha-syn alone does not. Our findings implicate that inducing reactive astrogliosis exacerbates PD-like pathologies and propose the virus combination as an advanced strategy for developing a new animal model of PD.
34045369	0	10	Adenovirus	Species	10508
34045369	19	40	Reactive Astrogliosis	Disease	MESH:D005911
34045369	70	89	Parkinson's Disease	Disease	MESH:D010300
34045369	91	110	Parkinson's disease	Disease	MESH:D010300
34045369	112	114	PD	Disease	MESH:D010300
34045369	138	170	neurodegenerative motor disorder	Disease	MESH:D019636
34045369	178	180	PD	Disease	MESH:D010300
34045369	226	231	death	Disease	MESH:D003643
34045369	325	346	reactive astrogliosis	Disease	MESH:D005911
34045369	373	375	PD	Disease	MESH:D010300
34045369	434	449	alpha-synuclein	Gene	6622
34045369	503	507	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	551	555	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	564	579	alpha-synuclein	Gene	6622
34045369	581	585	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	586	595	alpha-syn	Gene	6622
34045369	644	646	PD	Disease	MESH:D010300
34045369	718	739	reactive astrogliosis	Disease	MESH:D005911
34045369	755	770	alpha-synuclein	Gene	6622
34045369	824	829	human	Species	9606
34045369	830	832	PD	Disease	MESH:D010300
34045369	859	864	Adeno	Chemical	-
34045369	865	869	GFAP	Gene	2670
34045369	914	935	reactive astrogliosis	Disease	MESH:D005911
34045369	956	960	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	961	970	alpha-syn	Gene	6622
34045369	980	982	PD	Disease	MESH:D010300
34045369	1029	1036	AAV-CMV	Species	
34045369	1037	1041	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	1042	1051	alpha-syn	Gene	6622
34045369	1082	1087	Adeno	Chemical	-
34045369	1088	1092	GFAP	Gene	2670
34045369	1152	1172	tyrosine hydroxylase	Gene	7054
34045369	1202	1206	GFAP	Gene	2670
34045369	1253	1260	AAV-CMV	Species	
34045369	1261	1265	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	1266	1275	alpha-syn	Gene	6622
34045369	1280	1285	Adeno	Chemical	-
34045369	1286	1290	GFAP	Gene	2670
34045369	1326	1335	alpha-syn	Gene	6622
34045369	1359	1364	human	Species	9606
34045369	1365	1367	PD	Disease	MESH:D010300
34045369	1438	1445	AAV-CMV	Species	
34045369	1446	1450	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	1451	1460	alpha-syn	Gene	6622
34045369	1474	1483	alpha-syn	Gene	6622
34045369	1584	1586	PD	Disease	MESH:D010300
34045369	1592	1609	motor dysfunction	Disease	MESH:D000068079
34045369	1705	1710	Adeno	Chemical	-
34045369	1711	1715	GFAP	Gene	2670
34045369	1729	1736	AAV-CMV	Species	
34045369	1737	1741	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
34045369	1742	1751	alpha-syn	Gene	6622
34045369	1805	1826	reactive astrogliosis	Disease	MESH:D005911
34045369	1839	1841	PD	Disease	MESH:D010300
34045369	1954	1956	PD	Disease	MESH:D010300
34045369	Association	MESH:D010300	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
34045369	Positive_Correlation	MESH:D000068079	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
34045369	Association	MESH:D000068079	6622
34045369	Association	MESH:D010300	2670
34045369	Negative_Correlation	6622	7054
34045369	Negative_Correlation	2670	7054
34045369	Association	MESH:D010300	6622
34045369	Positive_Correlation	MESH:D005911	2670
34045369	Association	2670	6622
34045369	Association	MESH:D010300	6622
34045369	Association	MESH:D000068079	6622

